Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CLDN18.2 positive + HER-2 negative
i
Other names:
CLDN18, Claudin-18, Surfactant, Pulmonary Associated Protein J, Surfactant Associated 5, SFTA5, SFTPJ, ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2064
;
51208
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CLDN18.2 positive + HER-2 negative
Gastroesophageal Junction Adenocarcinoma
CLDN18.2 positive + HER-2 negative
Gastroesophageal Junction Adenocarcinoma
zolbetuximab-clzb
Sensitive: A1 - Approval
Precision Medicine Online - 3 weeks (New A1)
zolbetuximab-clzb
Sensitive
:
A1
Precision Medicine Online - 3wk
zolbetuximab-clzb
Sensitive: A1 - Approval
Precision Medicine Online - 3 weeks
zolbetuximab-clzb
Sensitive
:
A1
Precision Medicine Online - 3 weeks - (New A1)
CLDN18.2 positive + HER-2 negative
Gastric Cancer
CLDN18.2 positive + HER-2 negative
Gastric Cancer
zolbetuximab-clzb
Sensitive: A1 - Approval
Precision Medicine Online - 3 weeks (New A1)
zolbetuximab-clzb
Sensitive
:
A1
Precision Medicine Online - 3wk
zolbetuximab-clzb
Sensitive: A1 - Approval
Precision Medicine Online - 3 weeks
zolbetuximab-clzb
Sensitive
:
A1
Precision Medicine Online - 3 weeks - (New A1)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login